Aarey Drugs & Pharmaceuticals Limited (BOM:524412)

Market Cap	1.59B +43.9%
Revenue (ttm)	3.91B -33.0%
Net Income	34.35M -39.8%
EPS	1.19 -42.6%
Shares Out	28.45M
PE Ratio	46.81
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	18,116
Average Volume	4,603
Open	61.51
Previous Close	62.07
Day's Range	55.87 - 61.95
52-Week Range	33.00 - 100.00
Beta	0.52
RSI	36.75
Earnings Date	May 26, 2026

About BOM:524412

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1990
• Employees: 132
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524412

Financial Performance

In fiscal year 2025, BOM:524412's revenue was 4.74 billion, an increase of 17.73% compared to the previous year's 4.03 billion. Earnings were 40.24 million, a decrease of -14.09%.